Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)
CNY 33.96
(1.98%)
CNY 33.96
(1.98%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.29 CNY | -8.29% |
| 2022 | 2.05 CNY | 5.67% |
| 2021 | 1.94 CNY | 31.08% |
| 2020 | 1.48 CNY | 64.44% |
| 2019 | 0.90 CNY | -40.0% |
| 2018 | 1.50 CNY | 108.33% |
| 2017 | 0.72 CNY | 9.09% |
| 2016 | 0.66 CNY | 53.49% |
| 2015 | 0.43 CNY | 22.86% |
| 2014 | 0.35 CNY | 94.44% |
| 2013 | 0.18 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.63 CNY | 133.33% |
| 2024 Q2 | 0.28 CNY | -55.56% |
| 2024 Q3 | 0.40 CNY | 42.86% |
| 2023 Q4 | 0.27 CNY | -48.08% |
| 2023 FY | - CNY | -8.29% |
| 2023 Q3 | 0.52 CNY | -11.86% |
| 2023 Q2 | 0.59 CNY | 15.69% |
| 2023 Q1 | 0.51 CNY | 21.43% |
| 2022 Q2 | 0.68 CNY | 51.11% |
| 2022 Q1 | 0.45 CNY | -22.41% |
| 2022 FY | - CNY | 5.67% |
| 2022 Q4 | 0.42 CNY | -17.65% |
| 2022 Q3 | 0.51 CNY | -25.0% |
| 2021 Q2 | 0.62 CNY | 72.22% |
| 2021 Q1 | 0.36 CNY | -33.33% |
| 2021 FY | - CNY | 31.08% |
| 2021 Q3 | 0.57 CNY | -8.06% |
| 2021 Q4 | 0.58 CNY | 1.75% |
| 2020 FY | - CNY | 64.44% |
| 2020 Q1 | 0.34 CNY | 126.67% |
| 2020 Q2 | 0.56 CNY | 64.71% |
| 2020 Q3 | 0.39 CNY | -30.36% |
| 2020 Q4 | 0.54 CNY | 38.46% |
| 2019 Q3 | 0.17 CNY | -68.52% |
| 2019 Q2 | 0.54 CNY | 68.75% |
| 2019 Q1 | 0.32 CNY | 0.0% |
| 2019 FY | - CNY | -40.0% |
| 2019 Q4 | 0.15 CNY | -11.76% |
| 2018 FY | - CNY | 108.33% |
| 2017 FY | - CNY | 9.09% |
| 2016 FY | - CNY | 53.49% |
| 2016 Q1 | 0.15 CNY | 36.36% |
| 2016 Q2 | 0.15 CNY | 0.0% |
| 2015 Q2 | 0.11 CNY | -8.33% |
| 2015 Q1 | 0.12 CNY | 0.0% |
| 2015 Q4 | 0.11 CNY | 0.0% |
| 2015 FY | - CNY | 22.86% |
| 2014 FY | - CNY | 94.44% |
| 2013 FY | - CNY | 0.0% |